← Back to Clinical Trials
Recruiting NCT07381491

NCT07381491 Effects of Core Strengthening With Pelvic Proprioceptive Neuromuscular Facilitation on Trunk Control and Balance in Patients With Sub-acute Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07381491
Status Recruiting
Phase —
Sponsor Lahore University of Biological and Applied Sciences
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 38 participants
Start Date 2025-11-25
Primary Completion 2026-05-25

Eligibility & Interventions

Sex All sexes
Min Age 45 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Core stabilization exercisesPNFTrunk control exercises

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 38 participants in total. It began in 2025-11-25 with a primary completion date of 2026-05-25.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Purpose of this study was to investigate the effectiveness of core stabilization with pelvic proprioceptive neuromuscular facilitation on trunk control and balance which will be provided an evidence-based selection of the best possible intervention to improve trunk function and balance as compared to the trunk control exercises such as Rhythmic stabilization, Bridging, Side-Lying Trunk Lifts, Quadruped, Kneeling and modified plantigrade positioning, which one can provide the better balance and trunk control in sub-acute stroke patients.

Eligibility Criteria

Inclusion Criteria: * Participants between the ages of 45 and 60 years. * Sub-acute phase of unilateral ischemic stroke. * More than two weeks but no more than six months were included. * Participants should be able to walk with or without support for 2-4 min. * Participants with modified Ashworth scale grade 1 or grade 2. * Participants should be able to understand and follow simple verbal instructions (Mini-Mental Status Examination \[MMSE\]≥24). Exclusion Criteria: * Participants with recurrent stroke; brainstem or cerebellar stroke or hemorrhagic stroke. * Participants with modified Ashworth scale grade ≥3 (severe spasticity).

Contact & Investigator

Central Contact

Talha Mumtaz, Doctor of Physical Therapy

✉ drtalhamumtaz@gmail.com

📞 03351736446

Principal Investigator

NABEELA Dawood

STUDY CHAIR

Lahore University of Biological and Applied Sciences

Frequently Asked Questions

Who can join the NCT07381491 clinical trial?

This trial is open to participants of all sexes, aged 45 Years or older, up to 60 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07381491 currently recruiting?

Yes, NCT07381491 is actively recruiting participants. Contact the research team at drtalhamumtaz@gmail.com for enrollment information.

Where is the NCT07381491 trial being conducted?

This trial is being conducted at Rawalpindi, Pakistan.

Who is sponsoring the NCT07381491 clinical trial?

NCT07381491 is sponsored by Lahore University of Biological and Applied Sciences. The principal investigator is NABEELA Dawood at Lahore University of Biological and Applied Sciences. The trial plans to enroll 38 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology